Evaluation of the combination of psychosocial and pharmacological treatment in schizophrenic patients;Evaluación de la combinación de los tratamientos psicosocial y farmacológico en pacientes con esquizofrenia

Actas Espanolas de Psiquiatria

Volumn 30, Issue 6, 2002, Pages 358-369

  Valencia Collazos, M ^a   Ortega Soto, H A ^a   Rascon Gasca M L ^a   Gomez Caudillo L ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

Author keywords

Adherence; Antipsychotic medication; Pharmacological treatment; Psychosocial functioning; Psychosocial treatment

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; MALE; MEDICAL ASSESSMENT; MENTAL PATIENT; PATIENT COMPLIANCE; PSYCHIATRIC TREATMENT; RELAPSE; SCHIZOPHRENIA; SOCIAL PSYCHOLOGY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; SCHIZOPHRENIA; SOCIAL SUPPORT;

EID: 0036872396     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Delay J, Denicker P, Harl JM. Traitement états d'excitations et d'agitation par une methode médicamenteuse dérivée de l'hipernothérapie. Ann Med Psychol 1952;110:273-6.
2. Goffman E. Asylums: Essays on the social situation of mental patients and other inmates. New York: Anchor Book Edit; 1961.
3. Wing JK, Brown GW. Institutionalism and schizophrenia. London: Cambridge University Press; 1970.
4. Barton R. Institutional Neurosis. Bristol: Wright and Sons; 1959.
5. Stein L. A system approach to reducing relapse in schizophrenia. J Clin Psychiatry 1993;54:7-11.
6. Lieberman J. Prediction of outcome in first-episode schizophrenia. J Clin Psychiatry 1993;54:13-7.
7. Meyerson A. Theory and principles of the total push program for regressed schizophrenia. Am J Psychiatry 1964;95:1198-204.
8. Etzioni A. A comparative analysis of complex organizations. Glencoe: The Free Press; 1961.
9. Ryan P, Valencia M, Otero BR, Núñez M, González N, Rascón ML. Alternativas al hospitalismo. Rev Salud Mental 1982;5:8-15.
10. Brown GW. The mental hospital as an institution. Br J Psychiatry 1977;130:1-18.
11. Lagomarsino A. Psicoeducación para familias de esquizofrénicos. Acta Psiquiat Psicol Amer Lat 1990;36:73-80.
12. Herz MI. Early interventions in schizophrenia. En: Herz MI, Keith SJ, Docherty JP, editores. Psychosocial treatment of schizophrenia. Vol 4. Amsterdam: Elsevier Science Publishers; 1990. p. 25-44.
13. Liberman RP. Psychosocial treatment for schizophrenia. Psychiatry 1994;57:104-14.
14. Tarrier N, Haddock G, Barrowclough C. Training and dissemination: research to practice in innovative psychosocial treatments for schizophrenia. En: Wykes T, Tarrier N, Lewis S, editores. Outcome and innovation in psychological treatment of schizophrenia. Chichester: Wiley; 1998. p. 215-36.
15. Valencia M. El manejo comunitario de la esquizofrenia. En: Ortega H, Valencia M, editores. Esquizofrenia: Estado actual y perspectivas. México, D.F: Colección de libros del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz; 2001. p. 547-607.
16. Anthony W. The principles of psychiatric rehabilitation. Baltimore: University Park Press; 1980.
17. Bachrach LL. Psychosocial rehabilitation and psychiatry in the treatment of schizophrenia-what are the bundaries? Acta Psychiatr Scan 2000;407(102):6-10.
18. Llovet JM, Ballus C, Boada JC. Aspectos sociofamiliares en el tratamiento y rehabilitación de la esquizofrenia. Monografías de Psiquiatría 1991;2:25-34.
19. Bedell JR, Hunter RH, Corrigan PW. Current approaches to assessment and treatment of persons with serious mental illness. Professional Psychology: Research and Practice 1997;28:217-28.
20. Breeke J, Long J. Community based psychosocial rehabilitation and prospective change in functional, clinical and subjective experience variables in schizophrenia. Schizophrenia Bull 2000;26:667-80.
21. Brenner HD, Roder V, Hodel B, Kienzle N, Reed D. Integrated psychological therapy for schizophrenic patients. Seattle: Hogefre & Huber; 1994.
22. Buchkremer G, Klingberg S, Holle R, Schulze Monking H, Hornung WP. Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: results of a 2-year follow-up. Acta Psychiatr Scand 1997;96:483-91.
23. Wallace CJ, Liberman RP, Tauber R, Wallace J. The independent living skills survey: A comprehensive measure of the community functioning of severely and persistently mentally ill individuals. Schizophrenia Bull 2000;26:631-58.
24. Valencia M. Características clínicas y psicosociales de pacientes con esquizofrenia. En: Reporte interno del Instituto Nacional de Psiquiatría Ramón de la Fuente. México, D.F: 2001. p. 1-20.
25. Valencia M. Funcionamiento psicosocial en pacientes con esquizofrenia: treinta meses de seguimiento comunitario. Rev Salud Mental 1997;20:28-37.
26. Bellack AS, Mueser KT. Psychosocial treatment for schizophrenia. Schizophrenia Bull 1993;19:317-36.
27. Huxley N, Rendall M, Sederer LL. Psychosocial treatments in schizophrenia. A review of the past 20 years. The J of Nervous and Mental Disease 2000;188:187-201.
28. Kane JM. Management issues in schizophrenia. London: Martín Dunitz Ltd; 2000.
29. Harvard Medical School. The Harvard Mental Health Letter. The psychosocial treatment of schizophrenia-Part I 2001;18:1-4.
30. Marder SR. Integrating pharmacological and psychosocial treatments for schizophrenia. Acta Psychiatr Scan 2000;407:87-90.
31. May PRA. Treatment of schizophrenia. New York: Science House; 1968.
32. Ortega H, Valencia M. El tratamiento farmacológico de la esquizofrenia. En: Ortega H, Valencia M, editores. Esquizofrenia: Estado actual y perspectivas. México, D.F: Colección de libros del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz; 2001. p. 349-98.
33. Valencia M. Manejo psicosocial del paciente esquizofrénico. Rev Psiquiatría 1996;12:72-86.
34. Valencia M. Tratamiento psicosocial en pacientes esquizofrénicos del Instituto Mexicano de Psiquiatría. Rev Salud Mental 1999;2:31-40.
35. Valencia M. Programa de intervención psicosocial para pacientes esquizofrénicos crónicos. Rev Salud Mental 1999;22:128-37.
36. Valencia M. El tratamiento psicosocial en los pacientes con esquizofrenia. En: Ortega H, Valencia M, editores. Esquizofrenia: Estado Actual y Perspectivas. México, D.F: Colccción de libros del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz; 2001. p. 399-454.
37. Young M, Meltzer HS. The relationship of demographic, clinical and outcome variables to neuroleptic treatment requirements. Schizophrenia Bull 1980;6:88-100.
38. Liberman RP. Biobehavioral therapy: Interactions between pharmacotherapy and behavior therapy in schizophrenia. En: Wykes T, Tarrier N, Lewis S, editores. Outcome and Innovation in Psychological Treatment of Schizophrenia. Chichester: Wiley; 1998. p. 179-99.
39. Skinner BF. Science and Human Behavior. New York: McMillan; 1953.
40. Liberman RP. Handbook of psychiatric rehabilitation. New York: Allyn and Bacon; 1992.
41. Paul G, Lentz R. Psychocial treatment of the chronic mental patient. Cambridge, MA: Harvard University Press; 1977.
42. Liberman RP, Mueser KT, Wallace CJ, Jacobs HE, Eckman, Massel HK. Training skills in the psychiatrically disabled: Learning coping and competence. En: Straube ER, Hahlweg K, editores. Schizophrenia-Concepts, vulnerability, and intervention. Berlin: Springer; 1990. p. 194-216.
43. Malm U. Group therapy. En: Handbook of Schizophrenia. Vol 4. Psychosocial treatment of schizophrenia. Amsterdan: Elsevier Science Publishers; 1990. p. 191-211.
44. Hogarty GE. Prevention of relapse in chronic schizophrenic patients. J Clin Psychiatry 1993;54:18-23.
45. Johnson DA. Depot neuroleptics. En: Barnes TRF, editor. Antipsychotic drugs and their side-effects. London: Academic Press; 1993. p. 205-12.
46. Kissling W. Compliance, quality assurance and standards for relapse prevention in schizophrenia. Acta Psychiatr Scan 1994;89:16-24.
47. Babiker IE. Noncompliance in schizophrenia. Psychiatr Dev 1986;4:329-37.
48. Curson DA, Barnes TR, Bamber RW, Platt SD, Hirsch SR, Dutty JC. Long-term depot maintenance of chronic schizophrenic out-patients: the seven year follow-up of the Medical Research Council flufenazine/placebo trial. II The incidence of compliance problems, side-effects, neurotic symptoms and depression. Br J Psychiatry 1985;146:469-74.
49. Weiden P, Dixon L, Frances A. Neuroleptic non-compliance in schizophrenia. En: Tamminga C, Schulz C, editores. Advances in neuropsychiatry and psychopharmacology. Vol 1. Schizophrenia Research. New York: Raven; 1991. p. 285-96.
50. Bellack L. The Schizophrenia Syndrome. New York: Grunne & Sttraton; 1961.
51. Wing JKA. A pilot experiment on the rehabilitation of long hospitalized male schizophrenic patients. Br J of Prev and Soc Med 1960;14:173-80.
52. Wing JKA, Freuddenberg RK. The response of severely ill chronic schizophrenic patients to social stimulation. American J Psychiatry 1961;118:311-22.
53. Wing JKA, Brown GW. Institutionalism and Schizophrenia. London: Cambridge University Press; 1970.
54. Ayllon T, Michel J. The psychiatric nurse as a behavioural engineer. J Exp Analysis Behavior 1964;2:323.
55. Hogarty GE, Goldberg SC. Drug and sociotherapy in the aftercare of schizophrenic patients. Arch Gen Psychiatry 1973;28:54-64.
56. Bellack AS, Mueser KT. A comprehensive treatment program for schizophrenia and chronic mental illness. Community Mental Health J 1993;22:175-89.
57. Goldstein M, Rodnick E, Evans J, May P, Steinberg M. Drug and family therapy in the aftercare of acute schizophrenics. Arch Gen Psychiatry 1978;35:1169-77.
58. Gunderson JG, Frank A, Katz HM, Vanicelli ML, Frosch JP. Effects of psychotherapy in schizophrenia. Schizophrenia Bull 1984;10:564-98.
59. Schwartz BJ, Cecil A, Iqbal N. Psychosocial treatments of schizophrenia. Psychiatric Annals 1993;23:216-21.
60. Mojtabai R, Nicholson R, Carpenter B. Role of psychosocial treatments in the management of schizophrenia: A meta-analytic review of controlled outcome studies. Schizophrenia Bull 1998;24:569-87.
61. Ballus C, Llovet JM, Boada JC. La orientación terapéutica familiar en la esquizofrenia: Un modelo psicoeducativo sistémico. Reflexiones tras un año de seguimiento. Rev Psiquiatría Fac Med Barna 1991;18:71-8.
62. Mari JJ, Steiner D. An overview of family interventions and relapse on schizophrenia: meta-analysis of research findings. Psychological Medicine 1994;24:565-78.
63. Wallace CJ, Liberman RP, Mackain SJ, Black J, Eckman TA. Effectiveness and replicability of modules for teaching social skills to severely mental ill. Am J Psychiatry 1992;149:654-8.
64. Benton MK, Schoroeder HE. Social skills training with schizophrenics, meta-analytic evaluation. J Consulting Clin Psychology 1990;58:741-7.
65. Leff J, Berkowitz R, Shavit A, Strachan A, Glass Y, Vaughn CE. A trial of family therapy versus relatives groups for schizophrenia. Br J Psychiatry 1990;157:571-7.
66. Birchwood M, Tarrier N. Psychological management of schizophrenia. London: Wiley & Sons; 1994.
67. Chadwick P, Birchwood M, Trower P. Cognitive therapy for delusions, voices and paranoia. London: Wiley & Sons; 1996.
68. Fowler D, Garety P, Kuipers E. Cognitive behavior therapy for psychosis. London: Wiley & Sons; 1995.
69. Kingdom D, Turkington D. Cognitive behaviour therapy for schizophrenia. En: Wykes T, Tarrier N, Lewis S, editores. Outcome and innovation in psychological treatment of schizophrenia. Chichester: Wiley; 1998. p. 59-79.
70. Persons J, Mooney K, Padesky C. Inter-rater reliability of cognitive-behavioral case formulation. Cognitive Therapy and Research 1995;19:21-34.
71. Wykes T, Tarrier N, Lewis S. Outcome and innovation in psychological treatment of schizophrenia. Chichester: Wiley & Sons; 1998.
72. DiMascio A, Bernardo DL, Greenblandt DJ, Marder JE. A controlled trial of amantadine in drug-induced extrapiramidal disorders. Arch Gen Psychiatry 1976;33:599-602.
73. Valencia M. Formulación de principios de tratamiento y rehabilitación del paciente psicótico. Rev Mexicana de Psicología 1986;3:37-43.
74. Valencia M, Otero BR, Rascón ML. Un modelo de intervención clínica en un hospital mental. Acta Psiquiatr Psicol Am Latina 1986;32:41-51.
75. Valencia M. Un programa de tratamiento psicosocial para pacientes psicóticos agudos. Rev Psiquiatría 1998;12:72-86.
76. Valencia M. El hospital mental como instrumento terapéutico: El rol del psicólogo en la práctica clínica institucional. Rev Mexicana de Psicología 1991;8:99-107.
77. Asociación Psiquiátrica Americana. Manual diagnóstico y estadístico de los trastornos mentales, DSM-IV. Barcelona: Edit Masson; 1995.
78. Organización Mundial de la Salud. CIE-10. Trastornos mentales y del comportamiento. Descripción clínica y pautas para el diagnóstico. Espańa: OMS; 1992.
79. Kay S, Fizben A, Opler L. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull 1987;13:261-76.
80. Valencia M, Rojas E, González C, Ramos L, Villatoro J. Evaluación del funcionamiento psicosocial en pacientes de un centro de salud. Rev Salud Pública de México 1989;31:674-87.
81. Asociación Psiquiátrica Americana. Escala de evaluación de la actividad global-EEAG. Eje V, DSM-IV. Barcelona: Edit Masson; 1995.
82. Falloon IRH, Coverdale JH, Broker C. Psychosocial interventions in schizophrenia: A review. Int J Ment Health 1996;25:3-21.
83. Haug HJ, Wirz-Justice A, Rossler W. Actigraphy to measure day structure as a therapeutic variable in the treatment of schizophrenic patients. Acta Psychiatr Scand 2000;102 Suppl 407:91-5.
84. Meltzer HY. Outcome in schizophrenia: Beyond symptom reduction. J Clin Psychiatry 1999;60:3-7.
85. Penn DL, Mueser KT. Research update on the psychosocial treatment of schizophrenia. Am J Psychiatry 1996;153:607-17.
86. Lehman A. Commentary: What happens to pychosocial treatment on the way to the clinic. Schizophrenia Bull 2000;26(1):137-44.